polyDNA

Rates of the sexually transmitted infection dropped by 17 percent among women ages 15 to 25 from 2006 to 2010.

Researchers at Ohio State University are investigating what kind of effect stress has on the body’s immune system after being given the HPV vaccine.

A mid-stage study of an experimental drug against Hepatitis C being conducted by the pharmaceutical giant, Bristol-Myers Squibb Co.(BMY) is now canceled.

Two viruses may be able to collaborate with one another in order to promote the survival and production of cancer cells.

A strong patent has been granted to BioAlliance Pharma SA in connection with its new treatment against recurring labial herpes.

Researchers at Johns Hopkins University say they've developed mucous-penetrating nanoparticles that can get anti-herpes drugs into the vaginal walls and help prevent infection.

HPV is a risk factor for certain head and neck cancers. Its presence could make a significant difference in terms of survival for African Americans with throat cancer.

New Paper Shows that MPPs improve mucus penetration and drug retention.

HIV-positive women have a high risk of cervical cancer and as a result, are advised to undergo more frequent HPV screening tests.

The public believes it must absolutely use prescription drugs despite their unwanted side effects and despite their high cost in order to fight symptoms brought on by Hepatitis C.